Not strictly stem-cell news, but pertinent. There has been a distinct lack of M&A activity in the biotech market this year.
Amgen won the bidding to takeover Horizons Therapeutics (not Bio Horizons) in what is the biggest biotech takeover this year:
"The $27.8 billion deal is by far the largest biotech acquisition of a year that has seen less M&A activity than many investors had anticipated."
https://www.barrons.com/articles/amgen-horizon-therapeutics-acquisition-stock-price-51670843416
At the risk of loathing, I should mention J&J (and Sanofi) were in the running too. Given J&J didn't buy Horizons, they might now be able to afford to buy Orthocell (that was a joke).
- Forums
- ASX - By Stock
- Stem Cell Therapy advancements
Not strictly stem-cell news, but pertinent. There has been a...
-
- There are more pages in this discussion • 123 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add OCC (ASX) to my watchlist
|
|||||
Last
37.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $77.54M |
Open | High | Low | Value | Volume |
37.0¢ | 37.0¢ | 37.0¢ | $3.7K | 10K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 130052 | 36.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 9866 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 124923 | 0.365 |
12 | 153390 | 0.360 |
5 | 47268 | 0.355 |
7 | 102739 | 0.350 |
2 | 31889 | 0.345 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 9866 | 1 |
0.380 | 57716 | 3 |
0.385 | 45000 | 1 |
0.390 | 21421 | 4 |
0.395 | 30226 | 2 |
Last trade - 10.06am 20/08/2024 (20 minute delay) ? |
Featured News
OCC (ASX) Chart |